Target intelligence / Profile preview

General cellular toxicity

Molecular classification
Other
01

Overview

"General cellular toxicity" refers to the overall harmful effects that toxic substances—such as drugs, chemicals, environmental toxins, and biological agents—have on cells, resulting in cellular dysfunction, damage, or death. Toxicity can arise from direct damage to cellular components (such as DNA, proteins, and membranes) or disruption of essential cellular processes (such as metabolism, oxidative balance, or apoptosis regulation). Testing for cellular toxicity is fundamental in drug development and toxicology, often using cell culture models to quantify loss of cell viability, membrane integrity, energy production, or activation of death pathways. Since it represents an outcome rather than a specific molecular entity, "general cellular toxicity" is not considered a therapeutic target and lacks a specific gene, receptor, or protein that can be directly modulated by drugs[1][2][5][7][9]. Important caveat: "General cellular toxicity" is a broad toxicological outcome or assay endpoint, not a defined molecular target. If you require information about a specific protein (e.g., caspase, p53, sodium-potassium ATPase) involved in cell toxicity or a pharmacological target to mitigate toxicity, a precise molecule/gene/protein name should be provided.

Other names
cell toxicitycellular toxicitycytotoxicitytoxic cellular response
02

Mechanism of action

Induction of oxidative stress; Disruption of mitochondrial function; Inhibition of DNA replication/repair; Disruption of membrane integrity; Activation of cell death pathways (apoptosis, necrosis)

03

Biological functions

Cell deathCell damageApoptosisNecrosisDisruption of cell metabolismImpaired cell cycleInduction of oxidative stress
04

Disease associations

Cancer (drug toxicity, tumor cell killing)Neurodegenerative disease (from cell death)Organ dysfunction (general toxicity)InflammationOther (since it is a component of virtually all toxic pathology)
05

Safety considerations

Non-specific toxicity (off-target cell death)Organ-specific toxicity (liver, kidney, heart, brain, etc.)Idiosyncratic adverse reactionsDelayed or cumulative toxicity
06

Biomarkers

LDH release (lactate dehydrogenase, marker of membrane damage)Caspase activation (apoptosis marker)Annexin V labeling (apoptosis)Propidium iodide uptake (membrane rupture)Reduced ATP levelsIncreased reactive oxygen species (ROS)DNA fragmentation

Beyond the preview

Go deeper on General cellular toxicity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular toxicity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call